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Abstract
The oxygen requirement for chromophore formation
potentially limits the use of green fluorescent protein
as a reporter under hypoxic conditions. In the light of
this, the applicability of a hypoxia-responsive en-
hanced green fluorescent protein (EGFP)–based sys-
tem to the measurement of tumor hypoxia was tested
in human HT 1080 fibrosarcoma cells stably trans-
fected with a destabilized EGFP vector containing the
hypoxia-responsive 5HRE-hCMVmp promoter or, as a
positive control, the strong constitutive CMV promoter.
After various schedules of hypoxia and reoxygenation,
EGFP fluorescence of live cells was assessed by flow
cytometry, and protein levels were analyzed by West-
ern blot. Fluorescence of CMV promoter positive
control cells dropped to 38±5% of aerobic levels after
12 hours at <0.02% oxygen, but was unaffected by
higher oxygen concentrations. Following 12 hours at
<0.02% oxygen, cells transfected with the hypoxia-
responsive vector exhibited maximum fluorescence
after 4 hours of subsequent reoxygenation, reaching
68±2% of the levels in CMV promoter controls under
aerobic conditions. With such reoxygenation, these
cells exhibited a constant increase in fluorescence
between 2% and <0.02% oxygen. EGFP chromophore
formation is only affected by near -anoxic oxygen
concentrations. The correlation of fluorescence and
oxygen concentration is restored by a 4-hour reox-
ygenation period due to oxidation of pre-synthesized
EGFP and a delayed increase in EGFP protein
synthesis. Neoplasia (2001) 3, 527–534.
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Introduction
The cloning of the green fluorescent protein (GFP) gene
from Aequorea victoria and the subsequent development of
mutants with characteristics optimized for various applica-
tions have made GFP a powerful reporter for a wide range
of experimental designs [1–3]. The only fundamental
limitation to the widespread applicability of GFP has been
the requirement for molecular oxygen to dehydrogenate
the , bond of residue 66, which is necessary for
fluorescence [3]. This oxidation step is also the slowest
step in GFP chromophore formation with a time constant of
2 to 4 hours in vivo for wild- type GFP [4,5]. While it is
assumed that GFP cannot be expressed in obligate
anaerobes [3], it is unclear as to what extent low oxygen
concentrations affect chromophore formation in mammalian
cells.
The assessment of hypoxia and, potentially, the
selection of live cells based on oxygenation status are of
great interest for several fields of biomedical research,
including organ transplantation [6] and, in particular,
oncology: In recent years, tumor hypoxia has been shown
to be associated with poor clinical outcome in several
tumor sites after radiotherapy and chemotherapy [7–9].
Whereas bioreductive markers such as NITP, EF5, and
pimonidazole have been used extensively in tissue
sections and single cell suspensions to estimate the
oxygenation status of experimental and human tumors
[10–14], these methods require fixation of the respective
tissue or cells and make further analysis of live cells
impossible. An experimental system using GFP as a
marker of hypoxia would permit selection and further
analysis of live aerobic and hypoxic cells, e.g., in
clonogenic assays after in situ treatment. Here we describe
studies to examine the extent to which the requirement for
molecular oxygen by GFP interferes with accurate assess-
ment of hypoxia in cells transfected with a vector
containing a hypoxia- responsive promoter, and ways in
which the limitations may be overcome. We show that GFP
chromophore formation is only impaired at near-anoxic
conditions (<0.06%), and even this limitation can be
overcome by a 4-hour reoxygenation period after hypoxia.
With such reoxygenation, the hypoxia- responsive system
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is shown to exhibit a constant increase in fluorescence
with decreasing O2 concentrations below 2%.
Materials and Methods
Plasmid Construction
The methods for construction of a 5HRE-hCMVmp
promoter, consisting of five copies of a 35-bp fragment from
the hypoxia- responsive element (HRE) of the human VEGF
gene and a human cytomegalovirus minimal promoter
(hCMVmp), have been previously described for the con-
struction of a luciferase reporter vector [15]. In the present
study, the d2EGFP fragment from a Clontech (Palo Alto,
CA) vector, encoding a destabilized red-shifted variant of
wild- type GFP with an excitation maximum of 488 nm, an
emission maximum of 507 nm, and a half - life of approx-
imately 2 hours, was obtained by PCR using elongase
enzyme mixture (Gibco BRL, Gaithersburg, MD) to create
NcoI–NotI sites at the ends. The cDNA for the d2EGFP
fragment was digested and subcloned at NcoI–NotI sites of
a pEF/myc/cyto vector ( Invitrogen, Carlsbad, CA) to make
a C- terminal fusion with a c-myc epitope and checked by
sequencing. To generate a hypoxia- inducible expression of
the d2EGFP gene, the enhancer /promoter sequence
digested by KpnI and NcoI from a 5HRE-hCMVmp vector
was inserted into the pEF/myc/cyto vector containing
d2EGFP. A positive control vector was constructed by
insertion of the strong constitutive CMV promoter into the
d2EGFP vector.
Cell Culture and Transfection
The human HT 1080 human fibrosarcoma line was
obtained from the American Type Culture Collection
(Rockville, MD). Cells were cultured on glass Petri
dishes in  -MEM with 10% FCS at 378C with 5% CO2
in a well -humidified incubator. The 5HRE-hCMVmp-
d2EGFP and CMV-d2EGFP plasmids, respectively, were
stably transfected into tumor cells using a 3-hour
incubation with Superfect reagent (Qiagen, Valencia,
CA) and subsequent clonal selection in G-418 (400
g/ml) as described previously [16]. To obtain a
sufficient number of cells for the hypoxia experiments,
wild type and both types of transfected cells were
maintained in culture under non-selective conditions for
3 weeks. Portions of 2106 cells in 1 ml DMSO/ -MEM
(1:10) per vial were frozen at 808C.
Hypoxia Treatment
All experiments were performed on exponentially growing
cells from frozen stock with one further passage after plating.
Before each hypoxia treatment, the medium was changed.
The hypoxic marker EF5 (a generous gift of C. Koch,
University of Pennsylvania, Philadelphia, PA) was added at
a final concentration of 100 M if additional labeling was
desired. Hypoxia was achieved by a series of gas exchanges
with 95% N2/5% CO2 under standardized conditions [17],
producing oxygen concentrations of 20%, 6%, 2%, 0.6%,
0.2%, 0.06%, and <0.02%, respectively. After the end of the
treatment, cells were either immediately detached with
trypsin /EDTA, washed in  -MEM, and suspended in PBS
for flow cytometry or returned to the incubator for a
reoxygenation period and then processed.
Immunocytochemistry
Detection of the hypoxic marker EF5 was performed
according to published methods for flow cytometry [18].
Immediately after hypoxic treatment, cells were trypsinized,
washed in PBS, and fixed in 4% paraformaldehyde/PBS
for 60 minutes at 48C. After three rinses in PBS, 106 cells
were blocked overnight at 48C in PBS containing 0.3%
Tween 20, 1.5% albumin, 20% fresh skim milk, and 5%
normal mouse serum. Cells were then washed in PBS and
incubated at 48C for 6 hours in 100 l of PBS containing a
1:30 dilution of the ELK3-51 biotin antibody (generous gift
of C. Koch, University of Pennsylvania), a monoclonal
mouse antibody raised against EF5. After three 40-minute
washes in PBS containing 0.3% Tween 20 and 1.5%
albumin, cells were resuspended in a 1:100 dilution of
streptavidin R–phycoerythrin (PE) conjugate (Molecular
Probes, Eugene, OR) and incubated at 48C for 1 hour.
Cells were washed twice in PBS containing 0.3% Tween
20 and once in PBS.
Flow Cytometry
Cells were analyzed on a Becton Dickinson FacsCalibur
flow cytometer equipped with a 15-mW argon laser. Data
were analyzed using CellQuest software (Becton Dickinson,
San Jose, CA). Enhanced green fluorescent protein (EGFP)
fluorescence data were collected in the FL1 channel (530/
30) using log amplification. Twenty- thousand events were
collected for each sample. Dead cells and debris were
excluded based on forward-angle and side scatter. A clearly
distinguishable cell population with the background fluores-
cence level of non- transfected cells (<10% in each experi-
ment) was considered to have lost the transfection and was
also excluded from analysis. The percentage of such non-
transfected cells was not significantly affected by the hypoxic
treatment (6.8±0.9% in cells transfected with 5HRE-
hCMVmp-d2EGFP vector after 12 hours at <0.02% oxygen
and 8.6±0.2% in the same cells under aerobic conditions;
two-sided P>.05, Mann-Whitney U test ). When the anti-
body against the hypoxic marker EF5 was simultaneously
detected using the streptavidin R–PE conjugate, PE
fluorescence was detected in FL2 (585/42) and electronic
compensation was used (FL1 — 30% FL2; FL2 — 1.5%
FL1). Consistency of instrument settings was established
using the Linear Flow Green Flow Cytometry Intensity
Calibration Kit (Molecular Probes). Only minimal adjust-
ments of FL1 amplification were necessary between experi-
ments.
Western Blot Analysis
Cultured HT 1080 cells transfected with the 5HRE-
hCMVmp-d2EGFP vector were lysed in 1% Triton X-100
lysis buffer at different timepoints during reoxygenation after
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12 hours of hypoxia at <0.02% O2 or immediately after a
12-hour treatment at different oxygen concentrations. Total
protein was determined using the Bio-Rad DC protein
assay (Bio-Rad, Hercules, CA). For immunoblotting, whole
0.6%         0.2%  <0.02%
wild
type
5HRE
aerobic
CMV
aerobic
Figure 1. EGFP fluorescence in HT 1080 human fibrosarcoma cells transfected with the hypoxia - responsive 5HRE -hCMVmp-d2EGFP vector ( destabilized EGFP
protein, half - life 2 hours ), after treatment at oxygen levels between 20% ( ‘‘5HRE aerobic,’’ grey area ) or the concentrations indicated (black lines ) for 12 hours and
a subsequent 4 -hour reoxygenation period. Fluorescence of positive control cells transfected with CMV-d2EGFP vector ( ‘‘CMV aerobic,’’ grey area ) and of wild -
type HT 1080 cells ( grey area ) is shown for comparison. Gating for scatter and presence of transfection was performed. Not all oxygen concentrations are shown for
clarity. Flow cytometry data are from a representative experiment.
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Figure 2. Time course of EGFP fluorescence in HT 1080 human fibrosarcoma cells transfected with the hypoxia - responsive 5HRE -hCMVmp-d2EGFP vector
(destabilized EGFP protein, half - life 2 hours ), after reoxygenation following a 12 -hour hypoxia treatment at <0.02% oxygen (A ). Fluorescence in these cells is
given as the percentage of fluorescence in positive control cells transfected with CMV-d2EGFP vector (mean±SEM, n=4 ). Fluorescence of aerobic 5HRE-
hCMVmp-d2EGFP– transfected cells is indicated for comparison. Corresponding Western blot showing EGFP protein levels in whole cell lysates (B ). Cells
transfected with the CMV-d2EGFP vector serve as a positive control. Under aerobic conditions, cells transfected with the 5HRE -hCMVmp-d2EGFP vector ( 5HRE )
exhibit background fluorescence as compared to wild - type (WT) cells. After 12 hours of hypoxia at <0.02%, EGFP protein levels remain low at 0 and 2 hours of
reoxygenation, not accounting for the rapid increase in fluorescence shown in (A ) and thus suggesting an early chromophore oxidation of non - fluorescent EGFP
present at the end of the hypoxia treatment.
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cell lysates (30 g/ lane) were separated by SDS-PAGE
(10% polyacrylamide gel; Invitrogen) and transferred to a
nitrocellulose membrane ( Invitrogen) using a Novex Xcell II
semi-dry blotter ( Invitrogen). Membranes were blocked
overnight with 5% non- fat dry milk, 0.2% Tween-20 in PBS.
For EGFP detection, membranes were incubated with JL-8
monoclonal anti -GFP antibody (Clontech), recognizing all
GFP variants, for 2 hours at 1:1000 dilution in blocking
buffer and subsequently with secondary goat anti -mouse
IgG (H+L) AP antibody (Zymed, San Francisco, CA) for 1
hour at 1:5000 in blocking buffer. Detection was performed
with enhanced chemofluorescence (ECF; Amersham,
Piscataway, NJ).
Statistical Analysis
Data on the different schedules of hypoxia and
reoxygenation are given as mean±SEM from n=4 inde-
pendent experiments. Data are calculated as percentage of
fluorescence of aerobic positive control cells transfected
with the CMV-d2EGFP vector. However, absolute fluo-
rescence in these cells was very reproducible (see aerobic
cells in Figure 3 ).
Results
Time Course of EGFP Fluorescence and Protein Levels in
Cells Transfected with Hypoxia-Responsive Vector
The fluorescence in aerobic cells transfected with the
5HRE-hCMVmp vector was 5.4±0.4% of the aerobic
positive control CMV-d2EGFP cells, compared to
0.44±0.05% in non- transfected cells (see Figure 1 ),
indicating some responsiveness of the 5HRE-hCMVmp
promoter under aerobic conditions. The time course of
EGFP fluorescence in HT 1080 cells transfected with this
vector after 12 hours at the lowest achievable oxygen
concentration (<0.02%) and with 0 to 24 hours of
reoxygenation is shown in Figure 2A. Fluorescence
immediately after the 12-hour hypoxic treatment was higher
than in aerobic controls of the same cell type and increased
during the first 4 hours to reach a maximum of 67.8±2.1%
of positive control aerobic CMV-d2EGFP cells before
decreasing to 10.8±2.4% after 24 hours. EGFP protein
levels peaked between 4 and 12 hours of reoxygenation,
but remained low during the first 2 hours after the hypoxic
treatment (Figure 2B ), in contrast to the rapid increase of
fluorescence at the 1- and 2-hour timepoints in Figure 2A.
These results indicate that the increase in EGFP fluores-
cence following reoxygenation after 12 hours at near -
anoxic conditions (<0.02% oxygen) is the result of an early
increase in chromophore oxidation (0 to 2 hours) as well as
a delayed increase in EGFP protein levels (2 to 4 hours).
Effect of Duration of Hypoxia, Oxygen Concentration, and
Reoxygenation Period on EGFP Fluorescence and Protein
Levels
Fluorescence after hypoxic treatments of varying dura-
tion and oxygen concentration, with or without a subsequent
4-hour reoxygenation period (chosen based on the results
of Figure 2A ), was compared for cells transfected with the
hypoxia- responsive 5HRE-hCMVmp-d2EGFP vector and
with the positive control CMV-d2EGFP vector (Figure 3 ). A
A
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Figure 3. EGFP fluorescence in HT 1080 human fibrosarcoma cells trans-
fected with the hypoxia - responsive 5HRE -hCMVmp-d2EGFP vector ( desta-
bilized EGFP protein, half - life 2 hours ), after treatment at oxygen
concentrations between 20% and <0.02% for 1 hour (A ), 4 hours (B ) and
12 hours (C ), respectively, with or without a 4 - hour reoxygenation period.
Fluorescence is given as the percentage of fluorescence in positive control
cells transfected with CMV-d2EGFP vector (mean±SEM, n=4 ). Western
blot of EGFP protein in cells transfected with 5HRE -hCMVmp-d2EGPF
vector ( 5HRE ), immediately after 12 hours at different O2 concentrations, with
aerobic CMV- transfected and wild - type (WT) cells for comparison (D ). At
<0.02% O2, the EGFP protein level in 5HRE-hCMVmp-d2EGFP– trans-
fected cells is lower than at 0.06% or 0.2%, suggesting reduced EGFP protein
synthesis under near - anoxic conditions, and not only unoxidated chromo-
phore, as an explanation for the drop of fluorescence at the lowest oxygen
concentration in (C ).
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1-hour treatment, even at the lowest oxygen concentration,
had no effect on EGFP fluorescence (Figure 3A ). Four
hours of hypoxia at the lowest oxygen level reduced
fluorescence in positive control cells to 66±3%, an effect
that was largely recovered by the 4-hour reoxygenation
period (Figure 3B ). A similar increase in fluorescence was
observed with the 4-hour reoxygenation period in the cells
transfected with the 5HRE-hCMVmp-d2EGFP vector.
Twelve hours of hypoxia produced a sharp decrease in
EGFP fluorescence at <0.02% oxygen for both positive
control cells (CMV promoter) and for cells transfected with
the hypoxia- responsive promoter (Figure 3C ). Again, the
4-hour reoxygenation period restored fluorescence in the
CMV-transfected cells to near 100% levels, and mark-
edly increased fluorescence in cells transfected with the
5HRE-hCMVmp-d2EGFP vector. Significantly, there was
little or no difference between treatments with or without
reoxygenation at oxygen concentrations of 0.06% or
greater. With reoxygenation, there was a constant
increase in fluorescence between 2% and <0.02%
oxygen. After 12 hours at different oxygen concentra-
tions, cells transfected with the 5HRE-hCMVmp-d2EGFP
vector exhibited maximal EGFP protein levels at 0.06%
O2, but reduced levels after near-anoxic conditions
(Figure 3D ), corresponding to the pattern of fluorescence
seen after hypoxia without reoxygenation in Figure 3C .
Labeling with the Hypoxic Marker EF5
To investigate the feasibility of detecting a second signal
simultaneously with EGFP in this system and to correlate
EGFP fluorescence with a widely used hypoxic marker, EF5
was added to the medium before hypoxic treatment, and a
two-step reaction with the ELK3-51 biotin monoclonal
mouse antibody and subsequent incubation with a strepta-
vidin R–PE conjugate was performed immediately after
hypoxic treatment (Figure 4 ). In cells transfected with the
CMV-d2EGFP vector, fluorescence after 12 hours at
<0.02% O2 was lower than under aerobic conditions due to
immediate processing of cells for EF5 detection without
reoxygenation. Cells transfected with the 5HRE-hCMVmp-
d2EGFP vector exhibited some background fluorescence as
compared to wild - type negative controls under aerobic
conditions and showed a marked increase in both EGFP
and PE fluorescence after 12 hours of hypoxia at <0.02%.
These experiments show that the hypoxia marker EF5 and
EGFP driven by the hypoxia- responsive promoter label
essentially the same population of hypoxic cells and have a
similar dynamic range.
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Figure 4. Human HT 1080 fibrosarcoma cells, wild type or transfected with the hypoxia - responsive 5HRE -hCMVmp-d2EGFP vector or the positive control CMV-
d2EGFP vector under aerobic (20% oxygen ) or hypoxic ( <0.02% oxygen for 12 hours ) conditions. EGFP fluorescence versus streptavidin–PE fluorescence after
labeling with ELK3 -51 biotin, an antibody against the hypoxic marker EF5. Cells were processed for EF5 detection immediately after hypoxic treatment. The
populations were gated for scatter, and electronic compensation was applied. The data are from a representative experiment.
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Discussion
The two major limitations of GFPs as markers of gene
expression are the requirement of molecular oxygen for
formation of the fluorescent chromophore and a low
temporal resolution resulting from the slow oxidation rate
[3–5]. Although GFP has occasionally been used as a
marker of gene expression under hypoxic conditions [19],
no quantitative data on the effect of low oxygen
concentrations on fluorescence at the single cell level
have been published. Reid and Flynn [5] described
chromophore formation as a three-step intramolecular
reaction, consisting of protein folding, cyclization of the
chromophore tripeptide, and the slowest phase, oxidation
of the cyclized chromophore. In a report comparing the
properties of wild type and mutant GFPs detected in
anaerobically grown Escherichia coli cultures, fluorescence
was found to increase after admission of air with time
constants of 2 and 0.45 hour, respectively, in wild - type GFP
and its S65T mutant [20]. This finding may have led
investigators to choose reoxygenation periods of about 3
hours for detection of maximum fluorescence [19].
Here we used a strong hypoxia- responsive promoter
driving a destabilized EGFP vector, with a protein half - life
of 2 hours, to test whether a GFP-based system can be
applied to measure hypoxia. The promoter used has been
shown to be extremely hypoxia- responsive, exhibiting up
to 500- fold gene expression in transient transfection
reporter gene assays [15], thereby exceeding the hypoxia
responsiveness of other published HRE constructs [21],
and was therefore expected to provide a sufficient
dynamic range of EGFP fluorescence. Application of the
short half - life EGFP, as compared to a half - life of over
24 hours for non-destabilized EGFP [21], was expected
to improve the temporal resolution though at the expense
of the dynamic range of fluorescence. Cells transfected
with the same vector containing a constitutive CMV
promoter were studied in parallel to obtain a reference
level of EGFP fluorescence and to determine how hypoxic
conditions would effect EGFP fluorescence per se,
irrespective of hypoxia- responsive regulation of gene
expression.
As a first step, the time course of EGFP fluorescence
after maximum hypoxia (<0.02% oxygen) for 12 hours
was investigated. Whereas the cells transfected with the
hypoxia- responsive 5HRE-hCMVmp-d2EGFP vector
exhibited some response of the HREs under aerobic
conditions (12- fold increase of fluorescence compared to
wild- type cells ), their fluorescence was only 5% of that
observed in cells transfected with the non-hypoxia–
dependent CMV-d2EGFP vector (Figure 1 ). Such back-
ground fluorescence could be caused by an induction of
the transcription factor subunit HIF-1 by serum growth
factors under aerobic conditions, which has been demon-
strated in vascular smooth muscle cells [22] or a
constitutive expression of HIF-1 due to a mutation of a
tumor suppressor gene [23]. Following 12 hours of
hypoxia at <0.02% O2, fluorescence in cells with the
hypoxia- responsive vector reached a maximum of 68% of
the positive control after 4 hours of reoxygenation, thus
giving a dynamic range of approximately 13- fold. A
reoxygenation period of 4 hours was therefore used in
experiments with different hypoxia durations and oxygen
concentrations.
One-hour hypoxia treatments neither increased EGFP
fluorescence in cells with the hypoxia- responsive vector
nor did they affect fluorescence in positive control cells,
suggesting that only chronically hypoxic cells are recog-
nized by the system. After 4 or 12 hours at <0.02%
oxygen, but not at higher concentrations, a marked drop
in fluorescence occurred in the cells with the CMV
promoter, indicating that very low oxygen levels, but not
anoxia, allow for unimpaired formation of the fluorescent
chromophore. This is underlined by the nearly identical
curves of fluorescence versus oxygen concentration with
and without 4 hours of reoxygenation after 12-hour
treatment, in cells with the hypoxia- responsive vector,
above 0.06% oxygen (Figure 3C ). With prolonged
hypoxia (12 hours) and subsequent reoxygenation,
fluorescence in the hypoxia- responsive system increased
constantly with decreasing oxygen concentrations between
2% and <0.02%.
To determine whether the effect of reoxygenation after
near-anoxic treatment on EGFP fluorescence was solely
due to chromophore oxidation in pre-synthesized EGFP,
Western blot analysis of 5HRE-hCMV-d2EGFP–trans-
fected cells was performed in whole cell lysates obtained
at different timepoints after 12 hours at <0.02%. Although
higher than under aerobic conditions, EGFP protein levels
were found to be similarly low at 0 and 2 hours post-
hypoxia with maximum levels at 4, 8, and 12 hours
(Figure 2B ). In contrast, there was a rapid increase of
fluorescence during the first 2 hours of reoxygenation
(Figure 2A ). Considering the time course of GFP (S65T
mutant, as present in EGFP) fluorescence restoration after
reoxygenation from anoxia in a cell - free system, where
approximately 85% of maximum fluorescence was
reached within 1 hour after readmission of air [20], the
oxidation of existing EGFP protein is likely to be the main
mechanism explaining the initial fluorescence increase
during reoxygenation. The lagging increase in EGFP
protein synthesis observed between 4 and 12 hours of
reoxygenation can well account for the slow decrease in
fluorescence (Figure 2A ), which could not otherwise be
explained in light of the short half - life of the EGFP protein
used in the present study. The time course of EGFP
protein synthesis, as observed on Western blot analysis,
explains the effect of a reoxygenation period after the
shorter 4-hour treatment even at intermediate oxygen
concentrations (Figure 3B ): Activation of the HREs,
transcription, and translation of EGFP are not complete
during the 4-hour treatment, and continue, regardless of
oxygenation, during the additional 4 hours. Corresponding
to the fluorescence data (Figure 3C ), EGFP protein levels
immediately after 12-hour hypoxia increased with
decreased oxygen concentrations, except for lower protein
expression under near-anoxic conditions (Figure 3D ).
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After sufficient reoxygenation, the system presented
makes possible the sorting of live chronically hypoxic cells
from a tumor cell suspension based on EGFP fluorescence
by fluorescence-activated cell sorting (FACS). Potential
applications include the isolation of such cells after treatment
of experimental tumors in vivo with cytotoxic substances or
ionizing radiation for subsequent separate analysis by
survival assays in vitro. Furthermore, sorted cells could be
analyzed for mutation status or changes in response to
cytotoxic agents during reoxygenation. Obviously, a need to
reoxygenate for several hours would preclude the assess-
ment of any hypoxia-associated short - term changes in gene
expression. However, reoxygenation can be omitted if anoxic
cells do not need to be analyzed.
The range in which the hypoxia- responsive system
exhibits a correlation between EGFP fluorescence and O2
concentrations, i.e., between 2% and anoxia, is relevant for
studies of tumor hypoxia. Firstly, the fact that the tran-
scription factor subunit HIF-1, which has been found to be
mainly responsible for the regulation of the hypoxic
response, including the expression of angiogenic and
glycolytic enzymes [24,25], directly activates the HREs in
the system now studied underscores the biological relevance
of EGFP fluorescence. HIF-1 protein levels increased
modestly between 6% and 2%, but drastically below 2% O2
in HeLa S3 cells [26]. Whereas EGFP protein levels in
5HRE-hCMVmp-d2EGFP–transfected cells after 12 hours
at <0.02% O2 are in good agreement with published HIF-1
protein levels [26], the detection of EGFP fluorescence
seems to be less sensitive, not detecting increased EGFP
levels at 6% or 2% oxygen.
The effectiveness of the hypoxia- responsive system in
more severe hypoxia makes it particularly applicable to
studies of radiation resistance in hypoxic cells. Early in
vitro data indicated that the half -maximal effect of
radiation sensitivity enhancement by oxygen is around
0.5% O2 [27,28]. Multiple studies of invasive intratumoral
oxygen measurements using the Eppendorf oxygen
electrode have identified hypoxia as an adverse prognostic
factor, particularly in cervix and head and neck cancer,
based on the percentage of readings below 5 mm Hg [9]
or below 2.5 mm Hg [7] or a median of below 10 mm Hg
[29], the equivalent of about 0.7%, 0.3%, and 1.4% O2
concentrations, respectively. Finally, much of the experi-
ence gained with hypoxia in experimental systems is
based on the use of injectable nitroimidazole derivatives
such as pimonidazole and EF5, which form intracellular
adducts at below 10 mm Hg [11,12], corresponding to
about 1.4% O2, and have a similar pattern of O2
concentration-dependent fluorescence on flow cytometry
as the EGFP-based system [18].
In conclusion, EGFP can serve as a reporter protein of
tumor hypoxia, in spite of the oxygen requirement for
chromophore formation, if sufficient time is allowed for
reoxygenation. Anoxia lasting 1 hour or less and prolonged
hypoxia at O2 concentrations of at least 0.06% have no
detrimental effect on EGFP fluorescence in the system
investigated. The present data show that live cells can be
sorted based on their oxygenation status for further analysis.
As indicated by the successful labeling of the hypoxic marker
EF5, the EGFP signal can be simultaneously measured with
antibody-conjugated fluorochromes after 4% paraformalde-
hyde fixation. Whereas the hypoxic response of the EGFP-
based system may be cell type–specific, the availability of
other GFP mutants with different half - lives and spectral
characteristics leaves room for adjusting the system for
specific applications.
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